This firm-fixed-price purchase order contract, valued at $14,906.75, was awarded by the National Cancer Institute to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products. The contract is for the delivery of 30 different antibodies to support multi-parameter flow cytometric analyses of circulating immune subsets in over 230 clinical samples as part of a clinical trial protocol. The contract does not have a set-aside designation. Biolegend, a specialized supplier in the biomedical research field, has received numerous awards from various National Institutes of Health components and has also served as a subcontractor on Department of Defense contracts, demonstrating its capability to support a wide range of federal research initiatives across multiple agencies.
Generated 4/1/25, 10:47 AM